RNAC
Cartesian Therapeutics Inc.
$8.52
+$0.07(+0.83%)
48
Overall
40
Value
54
Tech
52
Quality
Market Cap
$205.43M
Volume
173.66K
52W Range
$5.98 - $26.20
Target Price
$35.29
Key Metrics Overview
| Market Cap | $205.43M | P/E Ratio | N/A |
| 52W High | $26.20 | 52W Low | $5.98 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -173.1% | 52W Position | 12.6% |
| Overall Score | 48 | Value Score | 40 |
| Quality Score | 52 | Technical Score | 54 |
Growth Analysis
| EPS Current Est | $-2.38 | EPS Next Est | $-3.33 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $8.52 | +0.8% | 173.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW